Brief: Lineage Cell Therapeutics Inc - Withdrew CIRM Grant Application Filed In June 2025 - SEC Filing
28/11/2025 21:22
Nov 28 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A: LINEAGE CELL THERAPEUTICS INC - WITHDREW CIRM GRANT APPLICATION FILED IN JUNE 2025 - SEC FILING LINEAGE CELL THERAPEUTICS INC - CO INTENDS TO RESPOND TO FEEDBACK FROM CIRM, TO RESUBMIT CIRM GRANT APPLICATION JAN 2026 - SEC FILING LINEAGE CELL THERAPEUTICS INC - WITHDRAWAL DOES NOT IMPACT OPC1 DEVELOPMENT - SEC FILING Further company coverage: LCTX.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million